A detailed history of Capital Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 648,918 shares of PFE stock, worth $17.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
648,918
Previous 685,065 5.28%
Holding current value
$17.4 Million
Previous $19.2 Million 2.03%
% of portfolio
0.39%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $1 Million - $1.13 Million
-36,147 Reduced 5.28%
648,918 $18.8 Million
Q2 2024

Jul 12, 2024

SELL
$25.26 - $29.6 $288,772 - $338,387
-11,432 Reduced 1.64%
685,065 $19.2 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $268,065 - $307,824
10,354 Added 1.51%
696,497 $19.3 Million
Q4 2023

Jan 05, 2024

SELL
$26.13 - $33.94 $847,003 - $1.1 Million
-32,415 Reduced 4.51%
686,143 $19.8 Million
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $1.29 Million - $1.51 Million
40,233 Added 5.93%
718,558 $23.8 Million
Q2 2023

Jul 11, 2023

BUY
$36.12 - $41.79 $216,142 - $250,071
5,984 Added 0.89%
678,325 $24.9 Million
Q1 2023

Apr 10, 2023

BUY
$39.39 - $51.28 $5.9 Million - $7.69 Million
149,910 Added 28.69%
672,341 $27.4 Million
Q4 2022

Jan 05, 2023

SELL
$41.75 - $54.5 $406,561 - $530,721
-9,738 Reduced 1.83%
522,431 $26.8 Million
Q3 2022

Oct 05, 2022

SELL
$43.76 - $53.42 $6,213 - $7,585
-142 Reduced 0.03%
532,169 $23.3 Million
Q2 2022

Jul 06, 2022

SELL
$46.53 - $55.17 $35,362 - $41,929
-760 Reduced 0.14%
532,311 $27.9 Million
Q1 2022

Apr 13, 2022

SELL
$45.75 - $56.69 $14.5 Million - $18 Million
-316,900 Reduced 37.28%
533,071 $27.6 Million
Q4 2021

Jan 10, 2022

BUY
$41.32 - $61.25 $790,286 - $1.17 Million
19,126 Added 2.3%
849,971 $50.2 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $1.04 Million - $1.33 Million
26,454 Added 3.29%
830,845 $35.7 Million
Q2 2021

Jul 14, 2021

BUY
$35.91 - $40.68 $383,662 - $434,625
10,684 Added 1.35%
804,391 $31.5 Million
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $1.55 Million - $1.74 Million
46,174 Added 6.18%
793,707 $28.8 Million
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $2.99 Million - $3.8 Million
89,248 Added 13.56%
747,533 $27.5 Million
Q3 2020

Oct 29, 2020

BUY
$31.75 - $37.25 $1.46 Million - $1.71 Million
45,953 Added 7.5%
658,285 $24.2 Million
Q2 2020

Jul 20, 2020

BUY
$30.12 - $36.54 $1.21 Million - $1.47 Million
40,218 Added 7.03%
612,332 $20 Million
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $2 Million - $2.86 Million
74,041 Added 14.87%
572,114 $18.7 Million
Q4 2019

Jan 21, 2020

BUY
$32.92 - $37.36 $1.02 Million - $1.15 Million
30,872 Added 6.61%
498,073 $19.5 Million
Q3 2019

Oct 24, 2019

BUY
$32.49 - $42.13 $829,762 - $1.08 Million
25,539 Added 5.78%
467,201 $16.8 Million
Q2 2019

Jul 17, 2019

BUY
$36.98 - $41.52 $1.15 Million - $1.29 Million
30,971 Added 7.54%
441,662 $19.1 Million
Q1 2019

Apr 11, 2019

BUY
$37.5 - $41.2 $380,212 - $417,726
10,139 Added 2.53%
410,691 $17.4 Million
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $1.41 Million - $1.6 Million
-36,576 Reduced 8.37%
400,552 $17.5 Million
Q3 2018

Oct 15, 2018

BUY
$34.47 - $41.81 $190,963 - $231,627
5,540 Added 1.28%
437,128 $19.3 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $285,046 - $303,887
8,643 Added 2.04%
431,588 $15.7 Million
Q1 2018

Apr 16, 2018

BUY
$31.91 - $37.02 $1.33 Million - $1.54 Million
41,655 Added 10.92%
422,945 $15 Million
Q4 2017

Jan 17, 2018

BUY
$33.26 - $35.29 $3.57 Million - $3.79 Million
107,339 Added 39.18%
381,290 $13.8 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $8.49 Million - $9.36 Million
273,951
273,951 $9.78 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.